PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery and Cancer, Imperial College, London, UK. j.stebbing@imperial.ac.uk volker.lauschke@ki.se.\', \'Department of Rheumatology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.\', \'Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.\', \'Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.\', \'BenevolentAI, Maple Street, London, UK.\', \'Department of Surgery and Cancer, Imperial College, London, UK.\', \'Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden.\', \'Department of Geriatric Medicine, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.\', \'CIBERFES, Ministerio de Economía y Competitividad, Madrid, Spain.\', \'Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, Pisa, University of Pisa, Italy.\', \'Department of Internal Medicine, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.\', \'Department of Pharmaceutical Medicine, Misericordia Hospital, Grosseto, Italy.\', \'Department of Medicine, Misericordia Hospital, Grosseto, Italy.\', \'Department of Radiology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.\', \'Department of Rheumatology, Hospital of Prato, Prato, Italy.\', \'Department of Internal Medicine, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.\', \'Hospital Network ASL Toscana Centro, Toscana, Italy.\', \'Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases-IRCCS, Rome, Italy.\', \'University of Singapore, Infectious Diseases Programme, Immunology Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore and Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), Singapore, Singapore.\', \'Karolinska Institutet, Department of Laboratory Medicine, Unit of Clinical Microbiology, and SE-17177, Stockholm, Sweden.\', \'Department of Hematology, School of Medicine, University of Ioannina, Ioannina, Greece.\', \'Department of Economics and Finance, University of Rome Tor Vergata, Rome Italy.\', \'RCSB Protein Data Bank, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.\', \'Departments of Anesthesia, Medicine, and Physiology, University of Toronto, Toronto, ON, Canada.\', \'Virology Unit, Department of Translational Research, University of Pisa, Pisa, Italy.\', \'The Angiogenesis Foundation, Cambridge, MA, USA.\', \'Department of Statistics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.\', \'Department of Pneumology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.\', \'Oxford Nanoimaging, Oxford, UK.\', \'Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.\', \'Department of Medical Genetics, Life Science Institute, University of British Columbia, Vancouver, BC, Canada.\', \'National Veterinary Institute, Uppsala, Sweden.\', \'Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. j.stebbing@imperial.ac.uk volker.lauschke@ki.se.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • eabe472410.1126/sciadv.abe4724
?:hasPublicationType
?:journal
  • Science advances
is ?:pmid of
?:pmid
?:pmid
  • 33187978
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.817
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all